You are here
Threat to Advair from cheap generics greets GSK's new CEO
EMMA Walmsley, GlaxoSmithKline's incoming CEO, will take over Britain's biggest drugmaker at a challenging time but the 47-year-old also inherits the flexibility to do deals and make key choices on new drugs.
Just four days before she moves into the top job on April 1, US
- CALL +65 6388 3838
- EMAIL email@example.com